Skip to content
healthcare.dev

VENLAFAXINE HYDROCHLORIDE

NDC 10135-825, VENLAFAXINE HYDROCHLORIDE, capsule, extended release, from Marlex Pharmaceuticals, Inc..

Product NDC
10135-825
Status
Listed
Labeler
Marlex Pharmaceuticals, Inc.
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA201272
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/10135-825 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • VENLAFAXINE HYDROCHLORIDE37.5 mg/1

Pharmacologic classes

Norepinephrine Uptake Inhibitors [MoA]; Serotonin Uptake Inhibitors [MoA]; Serotonin and Norepinephrine Reuptake Inhibitor [EPC]

Package NDCNDC-11Package
10135-825-10101350825101000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10135-825-10)
10135-825-301013508253030 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10135-825-30)
10135-825-751013508257515 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10135-825-75)
10135-825-901013508259090 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10135-825-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3c2e188f-76aa-a022-e063-6294a90abfc9

Use it

Look up 10135-825 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/10135-825 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 10135-825. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.